Zymergen Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 507
Employees
  • Stock Symbol
  • ZY
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $1.50
  • (As of Monday Closing)

Zymergen General Information

Description

Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based breakthrough products that deliver value to customers in a broad range of industries. A unique combination of biology, chemistry, software and automation enables the company to design and create new materials.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Materials
Other Commercial Products
Stock Exchange
NAS
Primary Office
  • 5980 Horton Street
  • Suite 105
  • Emeryville, CA 94608
  • United States
+1 (415) 000-0000

Zymergen Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Zymergen Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.50 $1.64 $1.28 - $46.05 $169M 103M 1.12M -$4.87

Zymergen Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 269,035 269,035
Revenue 16,743 16,743 13,284 15,419
EBITDA (326,393) (326,393) (233,068) (223,574)
Net Income (361,785) (361,785) (262,194) (236,803)
Total Assets 522,396 522,396 304,921 227,890
Total Debt 43,953 43,953 79,331 78,310
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zymergen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Zymergen Inc is a biofacturing company. Zymergen partners with nature to design, develop and manufacture bio-based break
Biotechnology
Emeryville, CA
507 As of 2021
00.000
0.000 0000-00-00
00000000 00.000

000000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000 0000000000 00000000
Seattle, WA
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

0000000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Roslin, United Kingdom
0 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zymergen Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arzeda Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
0000000 Corporation Roslin, United Kingdom 0 0000000000
000000 00000000 00 Formerly VC-backed Boston, MA 000 00.000 000000000 00.000
00000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 Venture Capital-Backed Berkeley, CA 000 0000 00000000000 0000
You’re viewing 5 of 5 competitors. Get the full list »

Zymergen Patents

Zymergen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190046916-A1 Metal-organic framework materials Pending 17-Jul-2017 000000000
CA-3029638-C Chemical substructure search query building and execution Active 05-Jul-2016 00000000000
CA-3029638-A1 Chemical substructure search query building and execution Granted 05-Jul-2016 00000000000
US-20180011899-A1 Complex chemical substructure search query building and execution Granted 05-Jul-2016
US-10318526-B2 Complex chemical substructure search query building and execution Active 05-Jul-2016 G06F16/2428 0
To view Zymergen’s complete patent history, request access »

Zymergen Executive Team (20)

Name Title Board Seat Contact Info
Jay Flatley Chief Executive Officer & Chairman
Enakshi Singh Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Aaron Kimball Chief Technology Officer, Technology
Subodh Deshmukh Chief Development Officer
Mina Kim JD Executive & Chief Legal Officer, Legal
You’re viewing 5 of 20 executive team members. Get the full list »

Zymergen Board Members (10)

Name Representing Role Since
Christine Gorjanc Zymergen Board Member 000 0000
Dipchand Nishar SoftBank Group Board Member 000 0000
Jay Flatley Zymergen Chief Executive Officer & Chairman 000 0000
Matthew Ocko DCVC Board Member 000 0000
Rohit Sharma Ph.D True Ventures Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Zymergen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zymergen Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zymergen‘s full profile, request access.

Request a free trial

Zymergen Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 16-May-2021 0000000000 000.00 Drug Discovery
0000000 19-Mar-2020 0000000000 000.00 Biotechnology 000000 00
Radiant Genomics 08-Jan-2018 Merger/Acquisition Other Commercial Services 000000 00
To view Zymergen’s complete acquisitions history, request access »

Zymergen Subsidiaries (2)

Company Name Industry Location Founded
Radiant Genomics Other Commercial Services Emeryville, CA 2012
0000000 Biotechnology Medford, MA 0000
To view Zymergen’s complete subsidiaries history, request access »